Hjem › Reumatoid arthritis › Illinois › Cicero
Reumatoid arthritis kliniske forsøg i Cicero, IL
4 studier for Reumatoid arthritis søger deltagere på steder i og omkring Cicero (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RekruttererFase 2
- Willow Rheumatology and Wellness /ID# 272691, Willowbrook · 11 mi væk
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
RekruttererFase 2
- Willow Rheumatology and Wellness PLLC, Willowbrook · 11 mi væk
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RekruttererFase 2
- Artiva Investigational Site Willowbrook, Willowbrook · 11 mi væk
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
RekruttererFase 2
- Research Site, Willowbrook · 11 mi væk
Reumatoid arthritis forsøg i andre byer
- Houston, TX11 studier
- New York City, NY10 studier
- Durham, NC8 studier
- Altoona, PA7 studier
- Aurora, CO7 studier
- Dallas, TX7 studier
- Boston, MA7 studier
- San Diego, CA6 studier
- Plantation, FL6 studier
- Chicago, IL6 studier
- Miami, FL5 studier
- West Palm Beach, FL5 studier
Andre studier i Cicero
- Ikke-småcellet lungecancer24 studier
- Lungecancer17 studier
- Prostatakræft14 studier
- Kræft (alle typer)13 studier
- Akut myeloid leukæmi11 studier
- Brystkræft11 studier
- Colorektal kræft10 studier
- Blærecancer8 studier
- Metastatisk cancer7 studier
- Melanom7 studier
- Kardiovaskulær sygdom7 studier
- Burkitts lymfom6 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.